Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03137459 · ClinicalTrials.gov registry record · NA
STAMP: Sharing and Talking About My Preferences
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 909
- Enrollment target
NCT03137459: Completed NA study, sponsored by Yale University.
NCT03137459 is a NA study that has completed, run by Yale University. The registered enrollment target is 909 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03137459, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 909 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of an individually transtheoretical model (TTM) tailored intervention on the completion of advance care planning (ACP) behaviors.
Primary Outcome
The primary outcome of the study is to assess the proportion of participants that have completed the four ACP behaviors. The measure will be coded as a binary outcome where 'yes' indicates the completion of all 4 behaviors and 'no' indicates no completing the 4 behaviors.
Interventions
- OTHER Usual Care
- BEHAVIORAL Transtheoretical Model (TTM) of health behavior change
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 909 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03137459 record still lists
NCT03137459 is an interventional study that assigns participants to a tested intervention. The registered 909 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03137459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03137459 about?
NCT03137459 is a clinical study titled "STAMP: Sharing and Talking About My Preferences". The purpose of this study is to examine the effect of an individually transtheoretical model (TTM) tailored intervention on the completion of advance care planning (ACP) behaviors.
What is the current status of trial NCT03137459?
This trial is currently completed. It is a NA study. The enrollment target is 909 participants. The study started on 2017-07-17. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03137459?
The interventions under investigation include: Usual Care (OTHER), Transtheoretical Model (TTM) of health behavior change (BEHAVIORAL).
Who is sponsoring clinical trial NCT03137459?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03137459's enrollment target sits among peer trials
909 124th of 2000 higher than 1,877 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI